Abstract Details

Title Predictors of Response to Placebo in Phase III Trials of Adjunctive Eslicarbazepine Acetate (ESL)

Topic Epilepsy/Clinical Neurophysiology (EEG)

Presentation(s) P1 - (-)

Poster/Presentation
Number 031

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
PRESENTER	No disclosure on file
	No disclosure on file
Todd Grinnell, PhD	Todd Grinnell, PhD has received personal compensation for serving as an employee of Sunovion Pharmaceuticals Inc..
Hailong Cheng	No disclosure on file